Silo Pharma, Inc. (NASDAQ:SILO) Sees Significant Drop in Short Interest

Silo Pharma, Inc. (NASDAQ:SILO) was the recipient of a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 130,600 shares, a drop of 16.1% from the February 13th total of 155,700 shares. Based on an average daily trading volume, of 2,910,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 3.0% of the company’s shares are sold short.

Silo Pharma Trading Down 0.7 %

SILO opened at $1.37 on Wednesday. Silo Pharma has a 12 month low of $0.77 and a 12 month high of $4.50. The business’s 50-day moving average price is $1.57 and its 200-day moving average price is $1.23.

Silo Pharma Company Profile

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.